The FDA approved new treatment option for patients with HER2-positive breast cancer
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification
On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…
The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human study
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
CDC published ACIP recommendations on the use of BioThrax
On Dec. 13, 2019, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee (ACIP)…
Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human Health Exposure Analysis Resource (HHEAR)
On Dec. 13, 2019, the Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human…
BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
Oregonian received life-saving heart valve repair without open-heart surgery
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
Georgia Tech alumni and co-founders of LymphaTech announced partnership with medi to launch medi vision garments
On Dec. 10, 2019, Georgia Institute of Technology alumni and co-founders of LymphaTech Nate Frank and Mike Weiler…
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
FDA approved new sickle cell treatment based on clincal trial resutls from UTHSC’s Kenneth Ataga, MD
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
The University of Tennessee Institute of Agriculture was awarded a grant to study cattle genomics
On Dec. 2, 2019, the University of Tennessee Institute of Agriculture announced it had received a grant by…
Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain tumors derive from a genetic event early in cellular development
On Nov. 25, 2019, Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
SEHA, Mayo Clinic entered joint venture to operate Sheikh Shakhbout Medical City in the United Arab Emirates
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
Biotechnology | CDC | FDA | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 10 new recruitment grants,…
Celgene acquired by Bristol-Myers Squibb
On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…
Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Ceres Nanosciences launched Nanotrap Virus Capture Kit
On Nov. 7, 2019, Ceres Nanosciences announced the commercial launch of the Nanotrap Virus Capture Kit. The Nanotrap…
Biotechnology | Diagnostics | Genomics | HIV | Infectious Disease | Life Science News | Therapeutics
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
FDA approved Fluzone High-Dose Quadrivalent for adults 65+ years of age for 2020-21 flu season
On Nov. 4, 2019, the U.S. Food and Drug Administration (FDA) approved Fluzone High-Dose Quadrivalent (Sanofi Pasteur) for…
Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
Biotechnology | Diagnostics | Life Science News | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…